Premier Path Wealth Partners, LLC

SEC CIK: 0001999925
Latest filing: Jul 21, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Premier Path Wealth Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of ALNY by Premier Path Wealth Partners, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−596−100.0%	Sold out	Holders
Q4 2025	596	$236.8K	<0.1%	+92+18.3%	Added	Holders
Q3 2025	504	$229.6K	<0.1%	+504	New	Holders